GABAergic Signaling Is Linked to a Hypermigratory Phenotype in Dendritic Cells Infected by Toxoplasma gondii

PLoS Pathogens

Volumn 8, Issue 12, 2012, Pages

  Fuks, Jonas M ^a,b   Arrighi, Romanico B G ^a,b   Weidner, Jessica M ^a,b   Kumar Mendu, Suresh ^c   Jin, Zhe ^c   Wallin, Robert P A ^a   Rethi, Bence ^a   Birnir, Bryndis ^c   Barragan, Antonio ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Swedish Institute for Communicable Disease Control   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; CHEMOKINE RECEPTOR CCR7;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL MOTILITY; CHEMOTAXIS; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; NORMAL HUMAN; PARASITE LOAD; PHENOTYPE; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; UPREGULATION;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL19; DENDRITIC CELLS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MICE; RECEPTORS, GABA-A; SIGNAL TRANSDUCTION; TOXOPLASMA; TOXOPLASMOSIS;

ANIMALIA; PROTOZOA; TOXOPLASMA GONDII;

EID: 84872049385     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003051     Document Type: Article

References (70)

1. Joynson DH, Wreghitt TJ (2001) Toxoplasmosis: a comprehensive clinical guide. Cambridge, UK: Cambridge University Press.
2. Dobrowolski JM, Sibley LD, (1996) Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 84: 933-939.
3. Channon JY, Seguin RM, Kasper LH, (2000) Differential infectivity and division of Toxoplasma gondii in human peripheral blood leukocytes. Infect Immun 68: 4822-4826.
4. Lambert H, Barragan A, (2010) Modelling parasite dissemination: host cell subversion and immune evasion by Toxoplasma gondii. Cell Microbiol 12: 292-300.
5. Lang C, Gross U, Luder CG, (2007) Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol Res 100: 191-203.
6. Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, et al. (2003) Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol 4 (5) (): 485-490.
7. Reis e Sousa C, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, et al. (1997) In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med 186: 1819-1829.
8. Mashayekhi M, Sandau MM, Dunay IR, Frickel EM, Khan A, et al. (2011) CD8alpha(+) Dendritic Cells Are the Critical Source of Interleukin-12 that Controls Acute Infection by Toxoplasma gondii Tachyzoites. Immunity 35: 249-259.
9. Steinman RM, Banchereau J, (2007) Taking dendritic cells into medicine. Nature 449: 419-426.
10. Alvarez D, Vollmann EH, von Andrian UH, (2008) Mechanisms and consequences of dendritic cell migration. Immunity 29: 325-342.
11. Forster R, Davalos-Misslitz AC, Rot A, (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 8: 362-371.
12. Sacks D, Sher A, (2002) Evasion of innate immunity by parasitic protozoa. Nat Immunol 3: 1041-1047.
13. Liu CH, Fan YT, Dias A, Esper L, Corn RA, et al. (2006) Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against Toxoplasma gondii infection in mice. J Immunol 177: 31-35.
14. Lambert H, Hitziger N, Dellacasa I, Svensson M, Barragan A, (2006) Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol 8: 1611-1623.
15. Lambert H, Vutova PP, Adams WC, Lore K, Barragan A, (2009) The Toxoplasma gondii-shuttling function of dendritic cells is linked to the parasite genotype. Infect Immun 77: 1679-1688.
16. Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gatel D, et al. (2006) CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107: 309-316.
17. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli AE, Denkers EY, (2008) Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J Immunol 181: 8485-8491.
18. Collantes-Fernandez E, Arrighi RB, Alvarez-Garcia G, Weidner JM, Regidor-Cerrillo J, et al. (2012) Infected dendritic cells facilitate systemic dissemination and transplacental passage of the obligate intracellular parasite Neospora caninum in mice. PLoS One 7: e32123.
19. Farrant M, Kaila K, (2007) The cellular, molecular and ionic basis of GABA(A) receptor signalling. Prog Brain Res 160: 59-87.
20. Olsen RW, Sieghart W, (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60: 243-260.
21. Bettler B, Kaupmann K, Mosbacher J, Gassmann M, (2004) Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev 84: 835-867.
22. Hoglund PJ, Adzic D, Scicluna SJ, Lindblom J, Fredriksson R, (2005) The repertoire of solute carriers of family 6: identification of new human and rodent genes. Biochem Biophys Res Commun 336: 175-189.
23. Soghomonian JJ, Martin DL, (1998) Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 19: 500-505.
24. Owens DF, Kriegstein AR, (2002) Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3: 715-727.
25. Khakhalin AS, (2011) Questioning the depolarizing effects of GABA during early brain development. J Neurophysiol 106: 1065-1067.
26. Entschladen F, Bastian P, Niggemann B, Zaenker KS, Lang K, (2004) Inhibition of cell migration via G protein-coupled receptors to opioid peptides and angiotensin. Ann N Y Acad Sci 1028: 320-328.
27. Entschladen F, Lang K, Drell TL, Joseph J, Zaenker KS, (2002) Neurotransmitters are regulators for the migration of tumor cells and leukocytes. Cancer Immunol Immunother 51: 467-482.
28. Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H, (2002) GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol 213: 1-47.
29. Geigerseder C, Doepner R, Thalhammer A, Frungieri MB, Gamel-Didelon K, et al. (2003) Evidence for a GABAergic system in rodent and human testis: local GABA production and GABA receptors. Neuroendocrinology 77: 314-323.
30. Hitziger N, Dellacasa I, Albiger B, Barragan A, (2005) Dissemination of Toxoplasma gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminescence imaging. Cell Microbiol 7: 837-848.
31. Birnir B, Korpi ER, (2007) The impact of sub-cellular location and intracellular neuronal proteins on properties of GABA(A) receptors. Curr Pharm Des 13: 3169-3177.
32. Steiger JL, Russek SJ, (2004) GABAA receptors: building the bridge between subunit mRNAs, their promoters, and cognate transcription factors. Pharmacol Ther 101: 259-281.
33. Sieghart W, Sperk G, (2002) Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2: 795-816.
34. Fukuchi M, Nii T, Ishimaru N, Minamino A, Hara D, et al. (2009) Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci Res 65: 35-43.
35. Wheeler DW, Thompson AJ, Corletto F, Reckless J, Loke JC, et al. (2011) Anaesthetic impairment of immune function is mediated via GABA(A) receptors. PLoS One 6: e17152.
36. Lambert H, Dellacasa-Lindberg I, Barragan A, (2011) Migratory responses of leukocytes infected with Toxoplasma gondii. Microbes Infect 13: 96-102.
37. Azuma H, Inamoto T, Sakamoto T, Kiyama S, Ubai T, et al. (2003) Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism. Cancer Res 63: 8090-8096.
38. Calogero AE, Hall J, Fishel S, Green S, Hunter A, et al. (1996) Effects of gamma-aminobutyric acid on human sperm motility and hyperactivation. Mol Hum Reprod 2: 733-738.
39. Noor S, Habashy AS, Nance JP, Clark RT, Nemati K, et al. (2010) CCR7-dependent immunity during acute Toxoplasma gondii infection. Infect Immun 78: 2257-2263.
40. John B, Ricart B, Tait Wojno ED, Harris TH, Randall LM, et al. (2011) Analysis of behavior and trafficking of dendritic cells within the brain during toxoplasmic encephalitis. PLoS Pathog 7: e1002246.
41. Diana J, Vincent C, Peyron F, Picot S, Schmitt D, et al. (2005) Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors. Clin Exp Immunol 141: 475-484.
42. Behar TN, Schaffner AE, Colton CA, Somogyi R, Olah Z, et al. (1994) GABA-induced chemokinesis and NGF-induced chemotaxis of embryonic spinal cord neurons. J Neurosci 14: 29-38.
43. Rane MJ, Gozal D, Butt W, Gozal E, Pierce WM Jr, et al. (2005) Gamma-amino butyric acid type B receptors stimulate neutrophil chemotaxis during ischemia-reperfusion. J Immunol 174: 7242-7249.
44. Gouwy M, Struyf S, Noppen S, Schutyser E, Springael JY, et al. (2008) Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol Pharmacol 74: 485-495.
45. Persson EK, Agnarson AM, Lambert H, Hitziger N, Yagita H, et al. (2007) Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii. J Immunol 179: 8357-8365.
46. Persson CM, Lambert H, Vutova PP, Dellacasa-Lindberg I, Nederby J, et al. (2009) Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infect Immun 77: 970-976.
47. Dellacasa-Lindberg I, Fuks JM, Arrighi RB, Lambert H, Wallin RP, et al. (2011) Migratory Activation of Primary Cortical Microglia upon Infection with Toxoplasma gondii. Infect Immun 79: 3046-3052.
48. Lachenmaier SM, Deli MA, Meissner M, Liesenfeld O, (2011) Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J Neuroimmunol 232: 119-130.
49. Alam S, Laughton DL, Walding A, Wolstenholme AJ, (2006) Human peripheral blood mononuclear cells express GABAA receptor subunits. Mol Immunol 43: 1432-1442.
50. Tian J, Chau C, Hales TG, Kaufman DL, (1999) GABA(A) receptors mediate inhibition of T cell responses. J Neuroimmunol 96: 21-28.
51. Bhat R, Axtell R, Mitra A, Miranda M, Lock C, et al. (2010) Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A 107: 2580-2585.
52. Bjurstom H, Wang J, Ericsson I, Bengtsson M, Liu Y, et al. (2008) GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol 205: 44-50.
53. Mendu SK, Akesson L, Jin Z, Edlund A, Cilio C, et al. (2011) Increased GABA(A) channel subunits expression in CD8(+) but not in CD4(+) T cells in BB rats developing diabetes compared to their congenic littermates. Mol Immunol 48: 399-407.
54. Soltani N, Qiu H, Aleksic M, Glinka Y, Zhao F, et al. (2011) GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc Natl Acad Sci U S A 108: 11692-11697.
55. Rosas-Ballina M, Tracey KJ, (2009) The neurology of the immune system: neural reflexes regulate immunity. Neuron 64: 28-32.
56. Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW, (2009) Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 16: 122-133.
57. Lee M, Schwab C, McGeer PL, (2011) Astrocytes are GABAergic cells that modulate microglial activity. Glia 59: 152-165.
58. Kuhn SA, van Landeghem FK, Zacharias R, Farber K, Rappert A, et al. (2004) Microglia express GABA(B) receptors to modulate interleukin release. Mol Cell Neurosci 25: 312-322.
59. Glykys J, Mody I, (2007) Activation of GABAA receptors: views from outside the synaptic cleft. Neuron 56: 763-770.
60. Floyer-Lea A, Wylezinska M, Kincses T, Matthews PM, (2006) Rapid modulation of GABA concentration in human sensorimotor cortex during motor learning. J Neurophysiol 95: 1639-1644.
61. Bjork JM, Moeller FG, Kramer GL, Kram M, Suris A, et al. (2001) Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder. Psychiatry Res 101: 131-136.
62. Jin Z, Jin Y, Kumar-Mendu S, Degerman E, Groop L, et al. (2011) Insulin reduces neuronal excitability by turning on GABA(A) channels that generate tonic current. PLoS One 6: e16188.
63. Zangiacomi V, Balon N, Maddens S, Tiberghien P, Versaux-Botteri C, et al. (2009) Human cord blood-derived hematopoietic and neural-like stem/progenitor cells are attracted by the neurotransmitter GABA. Stem Cells Dev 18: 1369-1378.
64. Bortone D, Polleux F, (2009) KCC2 expression promotes the termination of cortical interneuron migration in a voltage-sensitive calcium-dependent manner. Neuron 62: 53-71.
65. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, et al. (2003) Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 102: 672-681.
66. Dellacasa-Lindberg I, Hitziger N, Barragan A, (2007) Localized recrudescence of Toxoplasma infections in the central nervous system of immunocompromised mice assessed by in vivo bioluminescence imaging. Microbes Infect 9: 1291-1298.
67. Pepper M, Dzierszinski F, Wilson E, Tait E, Fang Q, et al. (2008) Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines. J Immunol 180: 6229-6236.
68. Norbury CC, Chambers BJ, Prescott AR, Ljunggren HG, Watts C, (1997) Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 27: 280-288.
69. Sallusto F, Lanzavecchia A, (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109-1118.
70. Barragan A, Sibley LD, (2002) Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. J Exp Med 195: 1625-1633.